Omnicell OMCL
NASDAQ OMCL
$34.37 -0.45 (-1.29%)
At close: Sep 4, 2026 · 4:00 PM EDT

Omnicell (OMCL) Shares Outstanding (2010 - 2026)

Omnicell's (OMCL) quarterly Shares Outstanding (Entity) came in at $45.6 million in Q2 2026, down 1.74% year-over-year from $46.4 million in Q2 2025, and little changed quarter-over-quarter from $45.5 million in Q1 2026.

Analysis

Omnicell (OMCL) Shares Outstanding (2010 - 2026) Analysis & Trends

Omnicell (OMCL) has reported Shares Outstanding (Entity) for 17 consecutive years, with $45.6 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Shares Outstanding (Entity) fell 1.74% year-over-year to $45.6 million in Q2 2026; TTM through Jun 2026 was $45.6 million, a 1.74% decrease from a year earlier, with the FY2025 full-year figure at $45.0 million, down 2.92% from the prior year.
  • Shares Outstanding (Entity) was $45.6 million for Q2 2026 at Omnicell, roughly flat from $45.5 million in the prior quarter.
  • Over five years, Shares Outstanding (Entity) peaked at $46.8 million in Q1 2025 and troughed at $44.2 million in Q1 2022.
  • A 5-year average of $45.4 million and a median of $45.5 million in 2023 frame the typical range for Shares Outstanding (Entity).
  • Across the five-year window, Shares Outstanding (Entity) increased 2.32% in 2022 and retreated 3.1% in 2025, its largest moves.
  • Over 5 years, Shares Outstanding (Entity) stood at $44.7 million in 2022, then climbed by 1.77% to $45.5 million in 2023, then grew by 1.85% to $46.4 million in 2024, then fell by 2.92% to $45.0 million in 2025, then climbed by 1.3% to $45.6 million in 2026.
  • The last three Shares Outstanding (Entity) figures came in at $45.6 million (Q2 2026), $45.5 million (Q1 2026), and $45.0 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn 1.74 Bn
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn 354.10 Mn
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn 1.28 Bn
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn 383.50 Mn
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn 1.47 Bn
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn 576.40 Mn
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn 493.20 Mn
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn 382.20 Mn
9 Resmed 32.94 Bn 31.47 Bn 861.22 Mn 145.52 Mn
10 Omnicell 1.57 Bn 1.28 Bn 152.94 Mn 45.61 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 45.61 Mn
Mar 31, 2026 45.32 Mn
Dec 31, 2025 45.97 Mn
Sep 30, 2025 45.54 Mn
Jun 30, 2025 46.79 Mn
Mar 31, 2025 46.60 Mn
Dec 31, 2024 46.05 Mn
Sep 30, 2024 46.15 Mn
Jun 30, 2024 45.95 Mn
Mar 31, 2024 45.73 Mn
Dec 31, 2023 45.21 Mn
Sep 30, 2023 45.33 Mn
Jun 30, 2023 45.13 Mn
Mar 31, 2023 44.89 Mn
Dec 31, 2022 44.40 Mn
Sep 30, 2022 44.44 Mn
Jun 30, 2022 44.22 Mn
Mar 31, 2022 44.25 Mn
Dec 31, 2021 43.48 Mn
Sep 30, 2021 43.65 Mn